Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hsi‐Hsiung Chiu"'
Publikováno v:
European journal of clinical investigationREFERENCES.
Background Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate (ADC) for the treatment of human epidermal growth factor receptor 2 (HER-2)-positive breast cancer. T-DM1 is based on the trastuzumab antibody and delivers a toxic agent into brea
Autor:
Shu-Wen Jao, Yi-Hung Kuo, Wen-Shih Huang, Hong-Hwa Chen, Chung-Wei Fan, Chien-Yuh Yeh, Chang-Chieh Wu, Tian-Yuh Liou, Jeng-Yi Wang, Jinn-Shiun Chen, Wen-Ko Tseng, Ko-Chao Lee, Meng-Chiao Hsieh, Hsi-Hsiung Chiu, Pao-Shiu Hsieh, Chia-Cheng Lee, Yuan-Chiang Chung
Publikováno v:
The Clinical Journal of Pain. 33:429-434
This study was conducted to evaluate the safety and efficacy of single sebacoyl dinalbuphine ester (SDE) injection (150 mg/2 mL) when administered intramuscularly to patients who underwent hemorrhoidectomy for postoperative long-acting analgesia.A to
Autor:
Bey Liing Mau, Yuen Liang Lai, Chin Yuan Tzen, Hsi Hsiung Chiu, Han Ming Chen, Wen Hsuan Cheng
Publikováno v:
Annals of surgical oncology. 15(4)
Prognostic factors that could select breast cancer patients with poor survival, and influence clinical trials of targeted therapy, are needed. However, the reported observations regarding the impact of PI3KCA mutation on breast cancers are controvers
Autor:
Chien-Yuh Yeh, Shu-Wen Jao, Jinn-Shiun Chen, Chung-Wei Fan, Hong-Hwa Chen, Pao-Shiu Hsieh, Chang-Chieh Wu, Chia-Cheng Lee, Yi-Hung Kuo, Meng-Chiao Hsieh, Wen-Shih Huang, Yuan-Chiang Chung, Tian-Yuh Liou, Hsi-Hsiung Chiu, Wen-Ko Tseng, Ko-Chao Lee, Jeng-Yi Wang, Yeh, Chien-Yuh, Jao, Shu-Wen, Chen, Jinn-Shiun
Publikováno v:
Clinical Journal of Pain; May2017, Vol. 33 Issue 5, p429-434, 6p